This inventor holds 4 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2012-2026.
Location History:
- Arnstein, DE (2012)
- Bad Homburg, DE (2022 - 2023)
Company Filing History:
Years Active: 2012-2026
Title: Simon Geissler: Innovator in Pharmaceutical Formulations
Introduction
Simon Geissler is a notable inventor based in Bad Homburg, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on innovative formulations that aim to improve medical treatments.
Latest Patents
Geissler's latest patents include a pharmaceutical formulation that features (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)methanol or its pharmaceutically acceptable salt. Another significant patent is for a solid pharmaceutical preparation of 3-Fluoro-4-[7-methoxy-3-methyl-8-(1-methyl-1H-pyrazol-4-yl)-2-oxo-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl]-benzonitrile, which includes a method of making the preparation and its medical uses.
Career Highlights
Simon Geissler is currently employed at Merck Patent GmbH, where he continues to develop innovative pharmaceutical solutions. His expertise in the field has led to advancements that benefit both the industry and patients.
Collaborations
Geissler has collaborated with notable coworkers such as Markus Weigandt and Martina Jeschke. Their combined efforts contribute to the success of their projects and the advancement of pharmaceutical research.
Conclusion
Simon Geissler is a prominent figure in the pharmaceutical industry, recognized for his innovative patents and contributions to medical science. His work continues to pave the way for new treatments and advancements in healthcare.